Allergy Therapeutics plc announced that Nick Wykeman Board Director has tendered his resignation, with effect from November 30, 2022, in order to pursue non-executive roles. Nick Wykeman, who has been a Director of Allergy Therapeutics for six years, remains in his role for six months and a search for his successor will now commence.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.83 GBX | +10.40% | +23.85% | +93.20% |
1st Jan change | Capi. | |
---|---|---|
+93.20% | 267M | |
+15.53% | 121B | |
+13.68% | 107B | |
-4.51% | 24.82B | |
+1.66% | 22.48B | |
-9.56% | 18.32B | |
-42.28% | 16.33B | |
-16.25% | 15.31B | |
+3.70% | 14.08B | |
+25.69% | 11.74B |
- Stock Market
- Equities
- AGY Stock
- News Allergy Therapeutics plc
- Allergy Therapeutics plc Announces Resignation of Nick Wykeman to Its Board Director, Effective from November 30, 2022